arrow

From NeuroLex

Jump to: navigation, search



Dobutamine

Name: Dobutamine
Description: A beta-2 agonist catecholamine that has cardiac stimulant action without evoking vasoconstriction or tachycardia. It is proposed as a cardiotonic after myocardial infarction or open heart surgery. (PubChem) Pharmacology: Dobutamine is a direct-acting inotropic agent whose primary activity results from stimulation of the beta-adrenoceptors of the heart while producing comparatively mild chronotropic, hypertensive, arrhythmogenic, and vasodilative effects. Dobutamine acts primarily on beta-1 adrenergic receptors, with little effect on beta-2 or alpha receptors. It does not cause the release of endogenous norepinephrine, as does dopamine. Dobutamine is indicated when parenteral therapy is necessary for inotropic support in the short-term treatment of patients with cardiac decompensation due to depressed contractility resulting either from organic heart disease or from cardiac surgical procedures. Mechanism of action: Dobutamine directly stimulates beta-1 receptors of the heart to increase myocardial contractility and stroke volume, resulting in increased cardiac output. Drug type: Approved. Small Molecule. Drug category: Adrenergic beta-Agonists. Cardiotonic Agents. Sympathomimetic. Sympathomimetics
Synonym(s): Dobutamina (INN-Spanish), Dobutamine Hcl, Dobutamine Hcl in Dextrose 5%, Dobutamine Hydrochloride, Dobutamine (Usan:Ban:Inn), Dobutamine (Usan), Dobutaminum (INN-Latin), Dobutrex, Inotrex, Racemic-Dobutamine
Has role: Drug
Super-category: Molecular entity
URL: http://www.drugbank.ca/drugs/DB00841
*Id: DB00841
Related to: Beta-1 adrenergic receptor
Link to OWL / RDF: Download this content as OWL/RDF


Contributors

Ccdbuser, Nifbot2



bookmark

*Note: Neurolex imports many terms and their ids from existing community ontologies, e.g., the Gene Ontology. Neurolex, however, is a dynamic site and any content beyond the identifier should not be presumed to reflect the content or views of the source ontology. Users should consult with the authoritative source for each ontology for current information.

Facts about DobutamineRDF feed
Commenttaken from DrugBank
CuratorAb  +
DefiningCitationhttp://www.drugbank.ca/drugs/DB00841  +
DefinitionA beta-2 agonist catecholamine that has ca A beta-2 agonist catecholamine that has cardiac stimulant action without evoking vasoconstriction or tachycardia. It is proposed as a cardiotonic after myocardial infarction or open heart surgery. (PubChem) Pharmacology: Dobutamine is a direct-acting inotropic agent whose primary activity results from stimulation of the beta-adrenoceptors of the heart while producing comparatively mild chronotropic, hypertensive, arrhythmogenic, and vasodilative effects. Dobutamine acts primarily on beta-1 adrenergic receptors, with little effect on beta-2 or alpha receptors. It does not cause the release of endogenous norepinephrine, as does dopamine. Dobutamine is indicated when parenteral therapy is necessary for inotropic support in the short-term treatment of patients with cardiac decompensation due to depressed contractility resulting either from organic heart disease or from cardiac surgical procedures. Mechanism of action: Dobutamine directly stimulates beta-1 receptors of the heart to increase myocardial contractility and stroke volume, resulting in increased cardiac output. Drug type: Approved. Small Molecule. Drug category: Adrenergic beta-Agonists. Cardiotonic Agents. Sympathomimetic. Sympathomimetics Agents. Sympathomimetic. Sympathomimetics
Has roleDrug  +
IdDB00841  +
LabelDobutamine  +
ModifiedDate14 April 2014  +
RelatedToBeta-1 adrenergic receptor  +
SuperCategoryMolecular entity  +
SynonymDobutamina (INN-Spanish)  +, Dobutamine Hcl  +, Dobutamine Hcl in Dextrose 5%  +, Dobutamine Hydrochloride  +, Dobutamine (Usan:Ban:Inn)  +, Dobutamine (Usan)  +, Dobutaminum (INN-Latin)  +, Dobutrex  +, Inotrex  +, and Racemic-Dobutamine  +